The enzymes involved in the initial degradative steps of lysine metabolism, lysine-2-oxoglutarate reductase and saccharopine dehydrogenase, were studied and their activities in different mammals compared. Values obtained in human, rat, pig, dog, cat, ox and sheep liver indicated that in vitro, appreciable degradation of lysine to saccharopine (4-6 nmol/min per mg ofprotein) occurred. The specific activity of saccharopine dehydrogenase in most species studied was higher than that of lysine-oxoglutarate reductase. The rate ofproduction ofglutamate from saccharopine in each animal species was investigated and related to the rate of production of a-aminoadipate. The rate of formation of lysine from saccharopine, catalysed by saccharopine oxidoreductase, was examined and correlated with the dietary intake of lysine in each species studied.
The enzymes involved in the initial degradative steps of lysine metabolism, lysine-2-oxoglutarate reductase and saccharopine dehydrogenase, were studied and their activities in different mammals compared. Values obtained in human, rat, pig, dog, cat, ox and sheep liver indicated that in vitro, appreciable degradation of lysine to saccharopine (4-6 nmol/min per mg ofprotein) occurred. The specific activity of saccharopine dehydrogenase in most species studied was higher than that of lysine-oxoglutarate reductase. The rate ofproduction ofglutamate from saccharopine in each animal species was investigated and related to the rate of production of a-aminoadipate. The rate of formation of lysine from saccharopine, catalysed by saccharopine oxidoreductase, was examined and correlated with the dietary intake of lysine in each species studied. Higashino et al. (1965) suggested that saccharopine may be a key intermediate in the degradative pathway of lysine in rats. They demonstrated that isolated rat liver mitochondria convert L-lysine into saccharopine in the presence ofa-oxoglutarate. Grove & Henderson (1968) were unable to confirm the role ofsaccharopine in L-lysine degradation in vivo in rats or to establish an alternative pathway. However, they observed the removal of the a-amino group from D-lysine to form pipecolic acid, thereby indicating the presence of two distinct pathways for lysine degradation.
Studies of hereditary metabolic disorders of lysine have contributed greatly to the elucidation of its degradative pathways. Hutzler & Dancis (1968) investigated the initial degradative step of lysine in humans. They demonstrated that an enzyme, lysine-2-oxoglutarate reductase, was able to catalyse conversion of lysine and a-oxoglutarate into saccharopine in vitro. Further studies on patients with hyperlysinaemia (Dancis et al., 1969) confirmed that these patients have a deficiency of lysine-2-oxoglutarate reductase. These studies have thus established the important role of lysine-2-oxoglutarate reductase and saccharopine in the degradation of lysine in humans.
The presence of saccharopine in human physiological fluids was first reported by Carson et al. (1968) who described a case of saccharopinuria. Later studies (Fellows, 1972) revealed that this metabolic disorder is caused by the absence of an enzyme, saccharopine dehydrogenase, which converts saccharopine into a-aminoadipate 8-semialdehyde and glutamate. From further studies of the metabolism of saccharopine on ox and human liver, Fellows (1972) and Wang & Lewis (1972) (1973) .
Methods
Desalting technique. Cation-exchange column chromatography was used for desalting the incubation media and amino acid fractions as described by Fellows (1973) .
Two-dimensional chromatography and high-voltage electrophoresis. Amino acids were separated and identified as described by Fellows (1973) .
Preparation of [glutamyl-14C] saccharopine. This was synthesized enzymically with a partially purified lysine-2-oxoglutarate reductase prepared from ox liver by the method of Hutzler & Dancis (1968 Liquid-scintillation counting. The amino acid spots were cut out from paper and shaken in 2ml ofaq. 50 % methanol at room temperature for 4h, then 15ml of Bray's (1960) scintillation fluid was added to the extract and counted in a Packard Tri-Carb liquid-scintillation counter after 4h of equilibrium in the counting chamber.
Quench correction was made by the method of Bell (1968) by using an automatic external standard.
Results and Discussion
The present findings suggest that, in the mammalian species studied, saccharopine is a key intermediate (Scheme 1) in the degradative pathway of lysine metabolism. The activity of lysine-2-oxoglutarate reductase (Table 1) is readily detected in all the species studied, the highest specific activity being recorded in the pig and sheep, the lowest in the dog. Values obtained in human and rat liver indicate that appreciable degradation of lysine to saccharopine occurs in vitro in these species. A small amount of free saccharopine has been found in normal mouse liver (Higashino et al., 1971 ). Saccharopine has not, however, been detected in the physiological fluids of normal humans (Carson, 1969) (Grove & Henderson, 1968 Table 3 . For each mammal studied they are lower than the respective value recorded (Table 2) for saccharopine dehydrogenase. Although NAD+ was found to be an essential cofactor for saccharopine dehydrogenase in each species, no additional cofactor was required for the oxidation of saccharopine to cx-aminoadipate. The number of steps involved in the degradation of saccharopine to oc-aminoadipate is therefore uncertain, although the specific activities recorded in Tables 2 and 3 indicate that at least two steps are involved. Paik et al. (1957) observed that E-N-acetyl-lysine can replace lysine for growing rats and maintain a growth rate close to that produced by the equivalent amount of L-lysine. This observation was supported by the discovery of an enzyme, c-lysine acylase, in rat tissues, which catalyses the hydrolysis of E-N-acetyllysine to lysine at a high rate. This is the only reported evidence that lysine is substituted by an amino acid which supports the growth of rats. Wang & Lewis (1972) reported that lysine can be synthesized from saccharopine in vitro. The enzyme involved, saccharopine oxidoreductase, was studied in various mammals and the results are recorded in Table 4 . The highest specific activity was found in the livers of ox and sheep; that in human liver was considerably lower, being only 17 % ofthat found in ox liver, and the mean values obtained for the dog and cat were the lowest. These results suggest that all mammals so far studied have the ability, in vitro, to synthesize lysine from saccharopine as precursor. The variation of the rate of lysine synthesis in these mammals may be interpreted to suggest that saccharopine oxidoreductase activity is correlated with the protein content of the animal's diet. Thus carnivorous animals, such as dogs and cats, receive adequate amounts of dietary lysine and consequently have a very low activity of saccharopine oxidoreductase. In contrast, herbivorous animals, such as ox and sheep, are fed on a diet containing a relatively low concentration of lysine, and consequently a high enzyme activity. An omnivorous diet, such as that of normal humans or rats, results in a relatively low saccharopine oxidoreductase activity.
The specific activity of saccharopine oxidoreductase in pig's liver (Table 4) is considerably higher than that of other omnivores and lower than that of the herbivores. This intermediate enzyme activity is possibly a reflexion of the animal's adaptation to a wide range of dietary intake.
The activity ofsaccharopine oxidoreductase in vitro From these initial studies it is suggested that the activity of saccharopine oxidoreductase in different mammals may be subject to genetic variation, and the mechanism ofcontrol may be repressed or induced by the intake of dietary lysine.
In studies on the amino acid requirements of man, Rose and his co-workers (Rose et al., 1955) determined the minimum lysine intake per day to be 0.8 g. From the present results on lysine formation from saccharopine in vitro (Table 5 ) it may be concluded that human liver may adequately meet this requirement. The rate of lysine formation in vivo would, however, be considerably lower since saccharopine does not normally accumulate. Lysine production in the rat (Table 5) is about 12 % of the daily minimum requirement (16 mg) reported by Neuberger & Webster (1945) . This is in contrast with our findings in the human, but when daily requirement of lysine is correlated with body weight, it appears that the rat (Neuberger & Webster, 1945 ) is considerably more dependent on dietary lysine than is the human (Rose, 1949) . In the ruminant, micro-organisms probably have some effect on amino acid requirements although the significance of the high'saccharopine oxidoreductase activity in ox liver (Table 5 ) may be a requirement for a more balanced supply of amino acids.
In contrast with the relative activity ofsaccharopine oxidoreductase in various mammals, the activities of lysine degradative enzymes (Tables 1, 2 and 3) do not appear to be correlated with the animal's diet. The activities of lysine-2-oxoglutarate reductase and saccharopine dehydrogenase in mammalian livers in vitro (Table 5 ), show that there is ample reserve of these two enzymes for the degradation of normal dietary lysine. In the human, for example, the liver alone has a capacity to metabolize about 40 g of lysine into saccharopine per day. Similarly, the conversion of saccharopine into oc-aminoadipate 8-semialdehyde and glutamate by saccharopine dehydrogenase shows ( Table 5) that human liver has a capacity to degrade 1 14g of saccharopine per day. If it is assumed that the results obtained from these studies in vitro reflect the capacity of the system in vivo, then the enzymes of mammalian liver should adequately metabolize the normal intake of dietary lysine. Also, since lysine is an essential amino acid for mammals, most of the ingested lysine would be used for the maintenance of N equilibrium and replacement of tissue protein.
The free lysine present in the body fluid would be limited. Under usual physiological conditions, it is unlikely that hyperlysinaemia or saccharopinuria would occur.
